INTRATHECAL ADMINISTRATION OF PROSTAGLANDIN E(2) CAUSES SENSITIZATIONOF THE PRIMARY AFFERENT NEURON VIA THE SPINAL RELEASE OF GLUTAMATE

Citation
Sh. Ferreira et Bb. Lorenzetti, INTRATHECAL ADMINISTRATION OF PROSTAGLANDIN E(2) CAUSES SENSITIZATIONOF THE PRIMARY AFFERENT NEURON VIA THE SPINAL RELEASE OF GLUTAMATE, Inflammation research, 45(10), 1996, pp. 499-502
Citations number
15
Categorie Soggetti
Pharmacology & Pharmacy",Chemistry
Journal title
ISSN journal
10233830
Volume
45
Issue
10
Year of publication
1996
Pages
499 - 502
Database
ISI
SICI code
1023-3830(1996)45:10<499:IAOPEC>2.0.ZU;2-F
Abstract
Objective and Design: The present investigation was aimed at assessing the involvement of primary sensory neurons in the hyperalgesia induce d by the intrathecal injection of PGE(2), as well as whether the hyper algesic effect was due to the spinal release of glutamate. Material: M ale Wistar rats were used. Methods: Hyperalgesia was measured using th e rat paw pressure test. Results: Intrathecal PGE(2) (2.5-50 ng/rat) a dministration caused a dose-dependent hyperalgesia in both paws. Ipsil ateral intraplantar injections of morphine (0.5-8 mu g/paw) or SNAP (S -nitroso-N-acetyl-D,L-penicillamine, 50-200) mu g/paw) dose-dependentl y antagonized spinally-induced PGE(2) hyperalgesia (ANOVA, p < 0.001). Their antinociceptive effects were confirmed to be peripheral by abol ition following pretreatment of the paws with L-NMMA (N-G-monomethyl-L -arginine monoacetate), 50 mu g/paw or with methylene blue (500 mu g/p aw). The spinally-induced PGE(2) hyperalgesia was antagonized by intra thecal injections (9 mu g) of AP5 (2-amino-5-phosphonopentanoate/2-ami no-5 a selective NMDA receptor antagonist. Conclusions: Intrathecal ad ministration of PGE(2) seems to cause hyperalgesia by spinal sensitiza tion of the primary afferent neuron through the release of glutamate.